NCT05515562View on ClinicalTrials.gov

Effects of Intravenous (IV) Omadacycline on Gut Microbiome

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

July 11, 2023

Study Completion Date

July 11, 2023

Conditions
Microbial Colonization
Interventions
DRUG

Omadacycline Injection

All participants will receive Intravenous (IV) omadacycline

Trial Locations (1)

27157

Wake Forest Baptist Health, Winston-Salem

Sponsors
All Listed Sponsors
collaborator

University of Houston

OTHER

collaborator

High Point University

OTHER

collaborator

Paratek Pharmaceuticals Inc

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER